Geun Woo Lee

Title: Geun Woo Lee: Innovator in Bacteriophage Research

Introduction

Geun Woo Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of bacteriophage research, focusing on compositions and methods for inhibiting the proliferation of pathogenic bacteria. With a total of two patents to his name, Lee's work is paving the way for innovative treatments against bacterial infections.

Latest Patents

Lee's latest patents include groundbreaking compositions and methods for preventing or treating infections caused by enterotoxigenic bacteria. One of his notable inventions involves a composition that utilizes a Siphoviridae bacteriophage (Bac-FRP-5) capable of lysing enterotoxigenic cells, combined with a pharmaceutically acceptable carrier. Additionally, he has developed a method that involves administering this bacteriophage to a subject to effectively combat infections. Another significant patent focuses on a Podoviridae bacteriophage (Esc-COP-30) that targets pathogenic bacteria, also accompanied by a suitable carrier. This method similarly involves administering the bacteriophage to treat infections caused by pathogenic bacteria.

Career Highlights

Geun Woo Lee is currently associated with Intron Biotechnology, Inc., where he continues to advance his research in bacteriophage technology. His work is instrumental in developing new therapeutic strategies that leverage the natural ability of bacteriophages to target and destroy harmful bacteria.

Collaborations

Lee collaborates with talented individuals in his field, including Seong Jun Yoon and Jee Soo Son. Their combined expertise enhances the innovative potential of their research projects.

Conclusion

Geun Woo Lee's contributions to bacteriophage research represent a significant advancement in the fight against bacterial infections. His innovative patents and ongoing work at Intron Biotechnology, Inc. highlight the importance of continued research in this vital area of medicine.